Biotech News
-
XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES November 26, 2021 (Source)…
-
Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY…
-
Zentek Ltd. Announces Filing of Preliminary Prospectus in Connection with $30,010,172 Offering
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. November 24, 2021 (Source)…
-
Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY…
-
DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE.
November 23, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader…
-
Element Nutritional Sciences Appoints Chief Marketing Officer
November 19, 2021 (Source) — Element Nutritional Sciences Inc. (CSE:ELMT; FRANKFURT:93X)(the “Company” or “Element”), is pleased to announce…
-
Sona Announces Research Collaboration with University of Toronto’s Institute of Biomedical Engineering
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April…
-
Sixth Wave On-Site Performance Testing of Affinity(TM) System
November 18, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Zentek Announces C$20 Million Bought Deal Public Offering and C$12.5 Million Non-Brokered Private Placement
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. November 16, 2021 (Source)…
-
Awakn Life Sciences Signs MOU with NHS (Devon Partnership NHS Trust) and University of Exeter with a View of Increasing Access to Psychedelic-Assisted Psychotherapy in the UK
With a Focus on Bringing the KARE Phase II a/b Trial (Ketamine-Assisted Psychotherapy for Alcohol Use Disorder) into…
